Multidrug resistance protein 2-mediated estradiol-17βcuronide transport potentiation: In vitro-in vivo correlation and species specificity

Drug Metabolism and Disposition

Volumn 37, Issue 4, 2009, Pages 794-801

  Heredi Szabo K ^a   Glavinas, H ^a   Kis, E ^a   Mehn D ^a   Bathori G ^a   Veres, Z ^b   Kobori L ^b   Von Richter, O ^c   Jemnitz, K ^b   Krajcsi, P ^a  

^a SOLVO BIOTECHNOLOGY   (Hungary)

^b CHEMICAL RESEARCH CENTER   (Hungary)

^c AiCuris GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL 17 GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN 2; VESICULAR TRANSPORT PROTEIN;

ANIMAL CELL; ARTICLE; ASSAY; BINDING SITE; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SPECIES DIFFERENCE;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ESTRADIOL; HEPATOCYTES; HUMANS; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RATS, WISTAR; SPECIES SPECIFICITY;

RATTUS;

EID: 63849091178     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.023895     Document Type: Article

References (38)

1. Bakos E, Evers R, Sinkó E, Varadi A, Borst P, and Sarkadi B (2000) Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol Pharmacol 57:760-768.
2. Bayliss MK and Skett P (1996) Human Cell Culture Protocols, pp 369-89, Humana Press, Totawa, NJ.
3. Bode KA, Donner MG, Leier I, and Keppler D (2002) Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate. Biochem Pharmacol 64:151-158.
4. Bodo A, Bakos E, Szeri F, Varadi A, and Sarkadi B (2003) Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J Biol Chem 278:23529-23537.
5. Borst P, Zelcer N, van de Wetering K, and Poolman B (2006a) On the putative co-transport of drugs by multidrug resistance proteins. FEBS Lett 580:1085-1093.
6. Borst P, Zelcer N, and van de Wetering K (2006b) MRP2 and 3 in health and disease. Cancer Lett 234:51-61.
7. 3H]estradiol-17/β(β-D-glucuronide) in isolated rat hepatocytes. Mol Pharmacol 32:519-523.
8. Buchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T, and Keppler D (1996) cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271:15091-15098.
9. Cui Y, König J, Buchholz JK, Spring H, Leier I, and Keppler D (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55:929-937.
10. Dayton PG, Yu TF, Chen W, Berger L, West LA, and Gutman AB (1963) The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. J Pharmacol Exp Ther 140:278-286.
11. Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, and Borst P (2000) Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 83:375-383.
12. Gerk PM, Li W, and Vore M (2004) Estradiol 3-glucuronide is transported by the multidrug resistance-associated protein 2 but does not activate the allosteric site bound by estradiol 17-glucuronide. Drug Metab Dispos 32:1139-1145.
13. Huisman MT, Chhatta AA, van Tellingen O, Beijnen JH, and Schinkel AH (2005) MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer 116:824-829.
14. Ito K, Suzuki H, and Sugiyama Y (2001) Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2. Mol Pharmacol 59:1077-1085.
15. Kartenbeck J, Leuschner U, Mayer R, and Keppler D (1996) Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 23:1061-1066.
16. Keppler D, Leier I, and Jedlitschky G (1997) Transport of glutathione conjugates and glucu-ronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791.
17. König J, Nies AT, Cui Y, Leier I, and Keppler D (1999) Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1461:377-394.
18. Liang E, Proudfoot J, and Yazdanian M (2000) Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res 17:1168-1174.
19. Liu X, LeCluyse EL, Brouwer KR, Gan LS, Lemasters JJ, Stieger B, Meier PJ, and Brouwer KL (1999) Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol 277(1 Pt 1):G12-G21.
20. Madon J, Eckhardt U, Gerloff T, Stieger B, and Meier PJ (1997) Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett 406:75-78.
21. Morikawa A, Goto Y, Suzuki H, Hirohashi T, and Sugiyama Y (2000) Biliary excretion of 17β-estradiol 17β-D-glucuronide is predominantly mediated by cMOAT/MRP2. Pharm Res 17:546-552.
22. Morita N, Kusuhara H, Nozaki Y, Endou H, and Sugiyama Y (2005) Functional involvement of rat organic anion transporter 2 (Slc22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen. Drug Metab Dispos 33:1151-1157.
23. Nies AT and Keppler D (2007) The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch 453:643-659.
24. Ninomiya M, Ito K, and Horie T (2005) Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2. Drug Metab Dispos 33:225-232.
25. Ninomiya M, Ito K, Hiramatsu R, and Horie T (2006) Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2). Drug Metab Dispos 34:2056-2063.
26. Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ, Tytgat GN, Borst P, Baas F, and Oude Elferink RP (1997) A mutation in the human canalicular multispecifi organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25:1539-1542.
27. Paulusma CC and Oude Elferink RP (1997) The canalicular multispecific organic anion trans porter and conjugated hyperbilirubinemia in rat and man. J Mol Med 75:420-428.
28. Sasaki M, Suzuki H, Aoki J, Ito K, Meier PJ, and Sugiyama Y (2004) Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2. Mol Pharmacol 66:450-459.
29. Shilling AD, Azam F, Kao J, and Leung L (2006) Use of canalicular membrane vesicles (CMVs from rats, dogs, monkeys and humans to assess drug transport across the canalicular mem brane. J Pharmacol Toxicol Methods 53:186-197.
30. Shitara Y, Li AP, Kato Y, Lu C, Ito K, Itoh T, and Sugiyama Y (2003) Function of uptak transporters for taurocholate and estradiol 17β-D-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 18:33-41.
31. Takeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, and Endou H (2002) Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther 302:666-671.
32. Terasaki T, Tamai I, Takanosu K, Nakashima E, and Tsuji A (1986) Kinetic evidence for a common transport route of benzylpenicillin and probenecid by freshly prepared hepatocytes in rats. Influence of sodium ion, organic anions, amino acids and peptides on benzylpenicillin uptake. J Pharmacobiodyn 9:18-28.
33. Toh S, Wada M, Uchiumi T, Inokuchi A, Makino Y, Horie Y, Adachi Y, Sakisaka S, and Kuwano M (1999) Genomic structure of the canalicular multispecific organic anion transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin Johnson syndrome. Am J Hum Genet 64:739-746.
34. Wada M, Toh S, Taniguchi K, Nakamura T, Uchiumi T, Kohno K, Yoshida I, Kimura A Sakisaka S, Adachi Y, et al. (1998) Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemi II/Dubin-Johnson syndrome. Hum Mol Genet 7:203-207.
35. Yamasaki Y, Ieiri I, Kusuhara H, Sasaki T, Kimura M, Tabuchi H, Ando Y, Irie S, Ware J, Naka Y, et al. (2008) Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans. Clin Pharmacol Ther 84:95-103.
36. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscheer P, Schellens JH Schinkel AH, and Borst P (2003) Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:23538-23544.
37. Zelcer N, van de Wetering K, de Waart R, Scheffer GL, Marschall HU, Wielinga PR, Kuil A Kunne C, Smith A, van der Valk M, et al. (2006) Mice lacking Mrp3 (Abcc3) have normal bil salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol 44:768-775.
38. Zimmermann C, van de Wetering K, van de Steeg E, Wagenaar E, Vens C, and Schinkel AH (2008) Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2). Drug Metab Dispos 36:631-640.